oxprenolol has been researched along with alprenolol in 98 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 65 (66.33) | 18.7374 |
1990's | 9 (9.18) | 18.2507 |
2000's | 17 (17.35) | 29.6817 |
2010's | 7 (7.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carrupt, PA; Gaillard, P; Schambel, P; Testa, B | 1 |
Artursson, P; Beigi, F; Lundahl, P; Luthman, K; Palm, K; Strandlund, G; Ungell, AL | 1 |
Ghuloum, AM; Jain, AN; Sage, CR | 1 |
Danelian, E; Hämäläinen, MD; Hansson, A; Karlén, A; Karlsson, R; Lennernäs, H; Löfâs, S; Winiwarter, S | 1 |
Topliss, JG; Yoshida, F | 1 |
Ertl, P; Rohde, B; Selzer, P | 1 |
Artursson, P; Luthman, K; Norinder, U; Stenberg, P | 1 |
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Caron, G; Ermondi, G | 1 |
Akamatsu, M; Fujikawa, M; Nakao, K; Shimizu, R | 1 |
Carrupt, PA; Guillarme, D; Henchoz, Y; Rudaz, S; Veuthey, JL | 1 |
Bard, B; Carrupt, PA; Martel, S | 1 |
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
Antonsson, M; Bengtsson, O; Bredberg, U; Fridén, M; Hammarlund-Udenaes, M; Jerndal, G; Wan, H; Winiwarter, S | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Akamatsu, M | 1 |
Ahlin, G; Bergström, F; Bredberg, U; Fridén, M; Hammarlund-Udenaes, M; Rehngren, M; Wan, H | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Pfeifer, S; Zimmer, C | 1 |
Miesch, F; Schwartz, J; Spach, MO | 1 |
Levy, JV | 1 |
Meier, J | 1 |
Darabi, MK; Hague, MA; Khalighi, MR | 1 |
Erdmann, E; Krawietz, W; Pruchniewski, M; Weinsteiger, M | 1 |
Dickerson, DD; Fulmor, IE; Goldberg, ME; Lee, RJ | 1 |
Day, MD; Roach, AG | 1 |
Kiechel, JR; Meier, J | 1 |
Prichard, BN | 2 |
Furukawa, K; Gotho, Y; Kubota, M | 1 |
Baker, I; Das Gupta, DS; Sowton, E | 1 |
Meurer, KA | 1 |
Dubach, UC | 1 |
Frisch, P | 1 |
Tuomilehto, J | 1 |
Nissinen, A; Tuomilehto, J | 1 |
Bigot, MC; DeBruyne, D; Kinsun, H; Moulin, MA | 1 |
Hansson, L; Werkö, L | 1 |
Fujita, T; Miyazaki, M; Nioka, S | 1 |
Jancinová, V; Nosál, R; Petríková, M | 1 |
Enquist, M; Hermansson, J | 1 |
Lozinskiĭ, LG; Sandomirskiĭ, BL; Zamotaev, IP | 1 |
Fishbein, L; Jackson, CD | 1 |
Abrahamsson, T | 1 |
Turner, P | 1 |
Bak, IJ; Grobecker, H; Hellenbrecht, D; Lemmer, B; Wiethold, G | 1 |
Goldstein, RE | 1 |
Górka, Z | 1 |
Gross, F | 1 |
Grobecker, H; Hellenbrecht, D; Lemmer, B; Wiethold, G | 1 |
Frankl, WS; Lawrence, T | 1 |
Blankart, R | 1 |
Garteiz, DA; Walle, T | 1 |
Gettes, LS | 1 |
Singh, BN | 1 |
Offerhaus, L | 1 |
Bagwell, EE; Williams, EM | 1 |
Gibson, DG | 1 |
Shand, DG | 1 |
Beumer, HM | 1 |
Furberg, CD | 1 |
Simpson, FO | 1 |
Jewitt, DE; Singh, BN | 1 |
Cottier, P | 1 |
Horii, D; Imai, S; Kawada, T; Takeda, K | 1 |
Walle, T | 1 |
Fujita, T; Miyazaki, M | 1 |
Gysling, E | 1 |
Roba, J | 1 |
Fitzgerald, JD | 1 |
Békés, M; Matos, L; Rausch, J; Török, E | 2 |
von Egidy, H | 1 |
Hampton, JR | 1 |
Le Douarec, JC; Lotti, VJ; Schmitt, C | 1 |
Brotelle, R; Colot, M; de Clavière, M; Heyndrickx, JP | 1 |
Helfert, I; Mácová, S; Trcka, V; Vanĕcek, M | 1 |
Siblíková, O; Trcka, V | 1 |
Ostman, J | 1 |
Friedewald, WT; Frishman, WH; Furberg, CD | 2 |
Battersby, LA; Cruickshank, JM; Prichard, BN | 1 |
Auerbach, DA; Aurbach, GD; Klein, DC; Woodard, C | 1 |
Walle, T; Walle, UK; Wilson, MJ | 1 |
Arnhold, J; Arnold, K; Seifert, T; Zschörnig, O | 1 |
Gemba, M; Hosaka, K; Kamiyama, M; Kobayashi, I; Konno, C; Maruo, H; Ueno, T | 1 |
Caldwell, GW; Evangelisto, M; Masucci, JA; White, R | 1 |
Caldwell, GW; Demarest, K; Easlick, SM; Gunnet, J; Masucci, JA | 1 |
Haginaka, J; Matsunaga, H | 1 |
Görlitzer, K; Lorenz, A | 2 |
Martinez-Gomez, MA; Medina-Hernández, MJ; Sagrado, S; Villanueva-Camañas, RM | 1 |
D'Orazio, G; Fanali, S | 1 |
Billiot, E; Billiot, F; Warner, IM | 1 |
Mizogami, M; Takakura, K; Tsuchiya, H | 1 |
Atarashi, R; Ishibashi, D; Ishikawa, T; Kamatari, YO; Kuwata, K; Miyazaki, Y; Nakagaki, T; Nishida, N; Takatsuki, H | 1 |
23 review(s) available for oxprenolol and alprenolol
Article | Year |
---|---|
[Biotransformation and pharmacokinetics of beta-receptor blockaders].
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Biotransformation; Ethanolamines; Humans; Isoproterenol; Kinetics; Levobunolol; Oxprenolol; Pindolol; Practolol; Propanolamines; Propranolol; Sotalol | 1975 |
[Comparative pharmacokinetics of beta-blockers].
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Half-Life; Humans; Metoprolol; Oxprenolol; Pindolol; Practolol; Propranolol; Sotalol; Timolol | 1978 |
Beta-adrenoceptor-blocking agents in the management of hypertension.
Topics: Adrenergic beta-Antagonists; Alprenolol; Blood Pressure; Brain; Cardiac Output; Drug Evaluation; Heart Rate; Humans; Hypertension; Neurons; Oxprenolol; Physical Exertion; Plasma Volume; Pressoreceptors; Propranolol; Renin; Temperature; Valsalva Maneuver | 1979 |
[Therapy and differential therapy with beta sympathicolytic drugs].
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Arrhythmias, Cardiac; Cardiomyopathy, Hypertrophic; Digitalis Glycosides; Drug Interactions; Ethanolamines; Humans; Hypertension; Long-Term Care; Oxprenolol; Pindolol; Propanolamines; Propranolol; Syndrome; Tachycardia | 1975 |
A toxicological review of beta-adrenergic blockers.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Cocarcinogenesis; Ethanolamines; Female; Kinetics; Labetalol; Lethal Dose 50; Male; Metoprolol; Mice; Mutagens; Nadolol; Neoplasms, Experimental; Oxprenolol; Pindolol; Practolol; Propanolamines; Propranolol; Rats; Sotalol; Timolol | 1986 |
Beta-adrenergic receptor blocking drugs in hyperthyroidism.
Topics: Adrenergic beta-Antagonists; Alprenolol; Antithyroid Agents; Ethanolamines; Humans; Hyperthyroidism; Iodine Radioisotopes; Oxprenolol; Pindolol; Practolol; Premedication; Propranolol; Sotalol; Sympathomimetics; Thyroidectomy | 1974 |
A comparison of beta-blocking agents.
Topics: Acetanilides; Adrenergic beta-Antagonists; Alprenolol; Amino Alcohols; Animals; Dogs; Dose-Response Relationship, Drug; Ethanolamines; Heart; Heart Rate; Humans; Oxprenolol; Propranolol; Propylamines; Sotalol | 1973 |
Beta-adrenergic receptor blocking drugs.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Aortic Aneurysm; Aortic Valve; Arrhythmias, Cardiac; Cardiomyopathy, Hypertrophic; Coronary Circulation; Heart Diseases; Humans; Hypertension; Migraine Disorders; Neurasthenia; Nitroglycerin; Oxprenolol; Pheochromocytoma; Propranolol; Receptors, Adrenergic; Sotalol; Tetralogy of Fallot | 1973 |
Beta adrenergic blocking drugs in the treatment of cardiac arrhythmias.
Topics: Adrenergic beta-Antagonists; Alprenolol; Arrhythmia, Sinus; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Digitalis Glycosides; Drug Therapy, Combination; Heart Conduction System; Heart Rate; Humans; Isoproterenol; Myocardial Infarction; Oxprenolol; Physical Exertion; Propranolol; Quinidine; Receptors, Adrenergic; Sotalol; Tachycardia, Paroxysmal | 1970 |
[Clinical application of beta-blockaders].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Anxiety Disorders; Arrhythmias, Cardiac; Cardiomyopathy, Hypertrophic; Humans; Hypertension; Hyperthyroidism; Oxprenolol; Pindolol; Practolol; Propranolol | 1973 |
Pharmacodynamic properties of beta-adrenergic receptor blocking drugs in man.
Topics: Adrenergic beta-Antagonists; Alprenolol; Blood Pressure; Cardiac Output; Catecholamines; Glycolysis; Heart; Heart Conduction System; Heart Rate; Hemodynamics; Humans; Lipid Metabolism; Oxprenolol; Oxygen Consumption; Physical Exertion; Pindolol; Practolol; Propranolol; Quinidine; Receptors, Adrenergic; Regional Blood Flow; Renin; Structure-Activity Relationship; Vasomotor System | 1974 |
Pharmacokinetic properties of the beta-adrenergic receptor blocking drugs.
Topics: Adrenergic beta-Antagonists; Adult; Alprenolol; Biopharmaceutics; Blood Proteins; Child; Half-Life; Heart Rate; Humans; Intestinal Absorption; Kinetics; Liver; Liver Circulation; Oxprenolol; Pindolol; Propranolol; Protein Binding | 1974 |
Beta-adrenergic receptor blocking drugs in angina pectoris.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Blood Pressure; Dose-Response Relationship, Drug; Drug Evaluation; Ethanolamines; Exercise Test; Heart Rate; Humans; Oxprenolol; Oxygen Consumption; Physical Exertion; Pindolol; Practolol; Propranolol; Sotalol | 1974 |
Adverse effects of beta-adrenergic receptor blocking drugs on respiratory function.
Topics: Adrenergic beta-Antagonists; Alprenolol; Asthma; Bronchi; Bronchial Spasm; Humans; Isoproterenol; Muscle, Smooth; Oxprenolol; Pindolol; Practolol; Propranolol; Respiration | 1974 |
Beta-adrenergic receptor blocking drugs in hypertrophic cardiomyopathy, autonomically mediated cardiovascular functional disorders and Fallot's tetralogy.
Topics: Adrenergic beta-Antagonists; Alprenolol; Cardiomyopathy, Hypertrophic; Cardiovascular Diseases; Drug Evaluation; Heart Rate; Humans; Oxprenolol; Pindolol; Placebos; Practolol; Propranolol; Tetralogy of Fallot | 1974 |
Beta-adrenergic receptor blocking drugs in hypertension.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Alprenolol; Antidepressive Agents; Antihypertensive Agents; Asthma; Diuretics; Drug Evaluation; Drug Therapy, Combination; Ganglionic Blockers; Heart Failure; Humans; Hypertension; Libido; Oxprenolol; Pindolol; Practolol; Propranolol; Psychopharmacology; Regional Blood Flow; Sotalol; Vasodilator Agents | 1974 |
Beta-adrenergic receptor blocking drugs in cardiac arrhythmias.
Topics: Action Potentials; Adrenergic beta-Antagonists; Alprenolol; Arrhythmia, Sinus; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Surgical Procedures; Catecholamines; Depression, Chemical; Digitalis Glycosides; Electrocardiography; Humans; Myocardial Infarction; Oxprenolol; Pacemaker, Artificial; Pindolol; Practolol; Propranolol; Purkinje Fibers; Tachycardia; Tachycardia, Paroxysmal; Ventricular Fibrillation; Wolff-Parkinson-White Syndrome | 1974 |
[Beta adrenergic drugs in arterial hypertension].
Topics: Action Potentials; Adrenergic beta-Antagonists; Alprenolol; Antihypertensive Agents; Blood Pressure; Cardiac Output; Ethanolamines; Heart Rate; Humans; Hypertension; Oxprenolol; Propranolol; Sympatholytics | 1972 |
The use of beta blockers for the reduction of mortality after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Atenolol; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Myocardial Infarction; Norway; Oxprenolol; Practolol; Propranolol; Random Allocation; Timolol | 1981 |
beta-adrenergic blockade and diabetes mellitus. A review.
Topics: Adrenergic beta-Antagonists; Alprenolol; Blood Glucose; Catecholamines; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Drug Synergism; Fatty Acids, Nonesterified; Gluconeogenesis; Glucose Tolerance Test; Glycerol; Glycogen; Humans; Hypertension; Hypoglycemia; Insulin; Lactates; Lactic Acid; Metoprolol; Oxprenolol; Propranolol | 1983 |
Beta-adrenergic blockade for survivors of acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Coronary Disease; Follow-Up Studies; Humans; Myocardial Infarction; Oxprenolol; Pindolol; Practolol; Propranolol; Sotalol; Time Factors; Timolol | 1984 |
The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Atenolol; Clinical Trials as Topic; Humans; Hypertension; Metoprolol; Myocardial Infarction; Oxprenolol; Pindolol; Practolol; Propranolol; Receptors, Adrenergic, beta; Risk; Sotalol; Timolol | 1984 |
Overdosage with beta-adrenergic blocking agents.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Alprenolol; Atropine; Blood Glucose; Cardiovascular System; Central Nervous System; Drug Tolerance; Heart Rate; Humans; Kinetics; Oxprenolol; Pindolol; Propranolol; Respiration; Sotalol | 1984 |
8 trial(s) available for oxprenolol and alprenolol
Article | Year |
---|---|
Comparative effects of beta adrenergic blocking drugs.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Clinical Trials as Topic; Electrocardiography; Exercise Test; Heart Rate; Hemodynamics; Humans; Injections, Intravenous; Oxprenolol; Pindolol; Placebos; Practolol; Propranolol; Sotalol | 1975 |
A comparison between metroprolol, alprenolol and oxprenolol in the treatment of hypertension.
Topics: Alprenolol; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Drug Evaluation; Follow-Up Studies; Humans; Hypertension; Metoprolol; Oxprenolol; Placebos; Propanolamines; Time Factors | 1979 |
Double-blind comparison of metoprolol, alprenolol, and oxprenolol in hypertension.
Topics: Adult; Aged; Alprenolol; Blood Pressure; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Male; Metoprolol; Middle Aged; Oxprenolol; Propanolamines | 1979 |
[Treatment of disorders of cardiac rhythm with beta-adrenoblockaders].
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Alprenolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Oxprenolol; Pindolol; Propanolamines; Propranolol | 1985 |
[Treatment of arterial hypertension using beta-blockaders].
Topics: Adrenergic beta-Antagonists; Alprenolol; Clinical Trials as Topic; Drug Evaluation; Humans; Hypertension; Oxprenolol; Pindolol; Practolol; Propranolol | 1974 |
The use of beta blockers for the reduction of mortality after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Atenolol; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Myocardial Infarction; Norway; Oxprenolol; Practolol; Propranolol; Random Allocation; Timolol | 1981 |
Beta-adrenergic blockade for survivors of acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Coronary Disease; Follow-Up Studies; Humans; Myocardial Infarction; Oxprenolol; Pindolol; Practolol; Propranolol; Sotalol; Time Factors; Timolol | 1984 |
The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Atenolol; Clinical Trials as Topic; Humans; Hypertension; Metoprolol; Myocardial Infarction; Oxprenolol; Pindolol; Practolol; Propranolol; Receptors, Adrenergic, beta; Risk; Sotalol; Timolol | 1984 |
70 other study(ies) available for oxprenolol and alprenolol
Article | Year |
---|---|
Binding of arylpiperazines, (aryloxy)propanolamines, and tetrahydropyridylindoles to the 5-HT1A receptor: contribution of the molecular lipophilicity potential to three-dimensional quantitative structure-affinity relationship models.
Topics: Indoles; Ligands; Models, Molecular; Molecular Conformation; Molecular Structure; Piperazines; Propanolamines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Structure-Activity Relationship; Tetrahydronaphthalenes | 1996 |
Evaluation of dynamic polar molecular surface area as predictor of drug absorption: comparison with other computational and experimental predictors.
Topics: Adrenergic beta-Antagonists; Amides; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Drug Design; Epithelial Cells; Formamides; Humans; Intestinal Absorption; Liposomes; Models, Molecular; Molecular Conformation; Monte Carlo Method; Permeability; Propanolamines; Structure-Activity Relationship | 1998 |
Molecular hashkeys: a novel method for molecular characterization and its application for predicting important pharmaceutical properties of molecules.
Topics: Drug Design; Intestinal Absorption; Models, Molecular; Pharmaceutical Preparations; Structure-Activity Relationship | 1999 |
SPR biosensor studies of the direct interaction between 27 drugs and a liposome surface: correlation with fraction absorbed in humans.
Topics: Humans; Intestinal Absorption; Liposomes; Pharmaceutical Preparations; Pharmacokinetics; Predictive Value of Tests; Surface Plasmon Resonance | 2000 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties.
Topics: Biological Availability; Biological Transport; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Reproducibility of Results | 2000 |
Experimental and computational screening models for the prediction of intestinal drug absorption.
Topics: Biological Transport; Carbon Radioisotopes; Cell Line; Cell Membrane; Cell Membrane Permeability; Ciprofloxacin; Computational Biology; Drug Design; Foscarnet; Humans; Hydrogen Bonding; Intestinal Absorption; Intestinal Mucosa; Lactulose; Mannitol; Models, Biological; Raffinose; Surface Properties; Tritium; Verapamil | 2001 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water | 2005 |
QSAR study on permeability of hydrophobic compounds with artificial membranes.
Topics: Biological Transport; Caco-2 Cells; Drug Evaluation, Preclinical; Humans; Hydrophobic and Hydrophilic Interactions; Membranes, Artificial; Permeability; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship | 2007 |
High-throughput log P determination by ultraperformance liquid chromatography: a convenient tool for medicinal chemists.
Topics: Chemical Phenomena; Chemistry, Pharmaceutical; Chemistry, Physical; Chromatography, Liquid; Mathematics; Pharmaceutical Preparations; Software | 2008 |
Lipophilicity of basic drugs measured by hydrophilic interaction chromatography.
Topics: Chemistry, Pharmaceutical; Chromatography; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Pharmaceutical Preparations; Solubility; Technology, Pharmaceutical | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Structure-brain exposure relationships in rat and human using a novel data set of unbound drug concentrations in brain interstitial and cerebrospinal fluids.
Topics: Animals; Blood-Brain Barrier; Brain; Extracellular Fluid; Humans; Linear Models; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Rats; Rats, Sprague-Dawley | 2009 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Importance of physicochemical properties for the design of new pesticides.
Topics: Anabasine; Animals; Biological Availability; Cell Membrane Permeability; Chemical Phenomena; Drug Design; Humans; Imidazoles; Insecticides; Neonicotinoids; Nitro Compounds; Pesticides; Quantitative Structure-Activity Relationship; Receptors, Nicotinic | 2011 |
Measurement of unbound drug exposure in brain: modeling of pH partitioning explains diverging results between the brain slice and brain homogenate methods.
Topics: Animals; Biological Transport; Brain; Chemical Phenomena; Dialysis; Hydrogen-Ion Concentration; In Vitro Techniques; Lysosomes; Male; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Tissue Distribution | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
[Comparison of the pA2 of various beta blocking agents].
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Dose-Response Relationship, Drug; Guinea Pigs; Heart Atria; In Vitro Techniques; Oxprenolol; Pindolol; Practolol; Propranolol; Trachea | 1975 |
Beta-adrenergic receptor blocking drugs in spontaneous hypertension.
Topics: Adrenergic beta-Antagonists; Aging; Alprenolol; Animals; Blood Pressure; Hypertension; Male; Metoprolol; Oxprenolol; Pindolol; Practolol; Propanolamines; Propranolol; Pulse; Rats; Rats, Inbred Strains; Sodium Chloride; Sotalol; Stereoisomerism; Time Factors | 1976 |
Pindolol: a pharmacokinetic comparison with other beta-adrenoceptor blocking agents.
Topics: Adrenergic beta-Antagonists; Alprenolol; Biological Availability; Half-Life; Humans; Metoprolol; Oxprenolol; Pindolol; Practolol; Propranolol; Protein Binding; Sotalol; Timolol | 1977 |
Comparative study of beta andreoceptor antagonists on the isolated atria of control and of the reserpine treated rabbits.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Arrhythmias, Cardiac; Female; Heart Atria; Heart Rate; Isoproterenol; Male; Oxprenolol; Practolol; Propranolol; Rabbits; Reserpine | 1977 |
[Properties of beta-adrenergic receptors of heart and lung--studies with "cardioselective" beta-receptor blocking substances].
Topics: Adrenergic beta-Antagonists; Alprenolol; Atenolol; Binding, Competitive; Heart; Lung; Metoprolol; Oxprenolol; Propranolol; Receptors, Adrenergic; Receptors, Adrenergic, beta | 1977 |
Direct myocardial depressant effects of several beta-adrenergic blocking agents in the unanesthetized atherosclerotic rabbit.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Arteriosclerosis; Atenolol; Blood Pressure; Depression, Chemical; Heart Rate; Isoproterenol; Male; Oxprenolol; Pindolol; Propanolamines; Propranolol; Rabbits; Timolol | 1978 |
The brain as a possible site for the cardiovascular effects of beta-adrenoceptor blocking agents in cats.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Blood Pressure; Brain; Cats; Female; Heart Rate; Injections, Intraventricular; Male; Oxprenolol; Pindolol; Practolol; Propranolol; Sotalol | 1975 |
[Cardiovascular effects of propanolol, alprenolol, oxprenolol and CS-359 during halothane anesthesia (author's transl)].
Topics: Adrenergic beta-Antagonists; Alprenolol; Anesthesia, Inhalation; Animals; Coumarins; Dogs; Halothane; Hemodynamics; Humans; Oxprenolol; Propanolamines; Propranolol | 1979 |
[Antihypertensive therapy using beta receptor blockers].
Topics: Adrenergic beta-Antagonists; Alprenolol; Cardiac Output; Heart Rate; Humans; Hypertension; Hypertension, Renal; Oxprenolol; Pindolol; Propranolol | 1975 |
[Editorial: Importance of cardioselectivity and sympaticomimetric potential of beta-blockers (author's transl)].
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Blood Vessels; Ethanolamines; Heart; Humans; Oxprenolol; Pindolol; Practolol; Propranolol; Sotalol; Sympathomimetics | 1975 |
Improved electron-capture GLC determination of alprenolol and oxprenolol in serum using a wall-coated open tubular column.
Topics: Alprenolol; Animals; Chromatography, Gas; Dogs; Humans; Methods; Oxprenolol | 1979 |
[Treatment of hypertension with beta blocking agents].
Topics: Alprenolol; Drug Therapy, Combination; Humans; Hypertension; Oxprenolol; Pindolol; Propranolol | 1975 |
[Use of various beta-adrenergic blockers in clinical anesthesia. (5) Clinical and experimental use of practolol (Eraldin)].
Topics: Adult; Alprenolol; Anesthesia, Inhalation; Animals; Arrhythmias, Cardiac; Dogs; Enflurane; Halothane; Humans; Middle Aged; Oxprenolol; Pindolol; Practolol; Propranolol | 1975 |
On the relationship between the inhibition of thrombin stimulated aggregation and thromboxane formation in isolated platelets treated with beta-adrenoceptor blocking drugs.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Arachidonic Acid; Atenolol; Blood Platelets; Male; Membrane Fluidity; Metipranolol; Oxprenolol; Platelet Aggregation Inhibitors; Practolol; Propranolol; Rats; Rats, Wistar; Thrombin; Thromboxane A2 | 1992 |
Separation of the enantiomers of beta-receptor blocking agents and other cationic drugs using a CHIRAL-AGP column. Binding properties and characterization of immobilized alpha 1-acid glycoprotein.
Topics: Adrenergic beta-Antagonists; Adsorption; Alprenolol; Atenolol; Binding Sites; Butylamines; Chromatography; Metoprolol; Molecular Structure; Orosomucoid; Oxprenolol; Pindolol; Propranolol; Protein Conformation; Spectrometry, Fluorescence; Stereoisomerism | 1990 |
The beta 1- and beta 2-adrenoceptor stimulatory effects of alprenolol, oxprenolol and pindolol: a study in the isolated right atrium and uterus of the rat.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Alprenolol; Animals; Female; Heart; Heart Atria; In Vitro Techniques; Isoproterenol; Male; Oxprenolol; Pindolol; Practolol; Propanolamines; Rats; Rats, Inbred Strains; Uterus | 1986 |
Human blood platelets as cellular models for investigation of membrane active drugs: beta-adrenergic blocking agents.
Topics: Adrenergic beta-Antagonists; Alprenolol; Amino Alcohols; Biological Transport; Blood Platelets; Carbon Isotopes; Cell Membrane Permeability; Humans; Kinetics; Microscopy, Electron; Models, Biological; Oxprenolol; Pindolol; Propranolol; Serotonin; Serotonin Antagonists; Sotalol; Tritium | 1972 |
Analysis of the hemodynamic action of beta-adrenolytics in narcotized cats.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Cats; Chemical Phenomena; Chemistry; Female; Hemodynamics; Male; Oxprenolol; Pindolol; Propranolol; Sotalol | 1973 |
[Current drugs. Therapy using -blockaders ( -adrenolytics)].
Topics: Acetanilides; Adrenergic beta-Antagonists; Alprenolol; Amino Alcohols; Angina Pectoris; Arrhythmias, Cardiac; Asthma; Ergoloid Mesylates; Humans; Hypertension; Oxprenolol; Pindolol; Propranolol; Propylamines | 1973 |
Measurement of hydrophobicity, surface activity, local anaesthesia, and myocardial conduction velocity as quantitative parameters of the non-specific membrane affinity of nine -adrenergic blocking agents.
Topics: 1-Propanol; Absorption; Acetanilides; Adrenergic beta-Antagonists; Alprenolol; Amino Alcohols; Anesthetics, Local; Animals; Anura; Butylamines; Cresols; Ethanolamines; Heart Conduction System; In Vitro Techniques; Membranes; Nitrobenzenes; Oxprenolol; Phenethylamines; Phenols; Pindolol; Propranolol; Propylamines; Sotalol; Structure-Activity Relationship; Surface Tension; Surface-Active Agents; Water | 1973 |
[Basis for the use of beta-receptor blockaders in the practice].
Topics: Acetanilides; Adrenergic beta-Antagonists; Alprenolol; Amino Alcohols; Humans; Oxprenolol; Pindolol; Propranolol; Propylamines; Sympathetic Nervous System | 1973 |
Electron impact fragmentation studies of beta-blocking drugs and their metabolites by GC-mass spectroscopy.
Topics: Acetates; Adrenergic beta-Antagonists; Alprenolol; Chemical Phenomena; Chemistry; Chromatography, Gas; Dealkylation; Fluorine; Isoproterenol; Mass Spectrometry; Oxprenolol; Propranolol; Sotalol; Structure-Activity Relationship | 1972 |
Clinical aspects of the anti-arrhythmic actions of beta-receptor blocking drugs. 2. Clinical pharmacology.
Topics: Adrenergic beta-Antagonists; Alprenolol; Arrhythmias, Cardiac; Drug Therapy, Combination; Heart Failure; Humans; Oxprenolol; Pindolol; Practolol; Propranolol; Quinidine; Stereoisomerism; Structure-Activity Relationship | 1973 |
Further studies regarding the structure activity relationships of beta-adrenoceptor antagonists.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Aorta; Dogs; Heart; Isoproterenol; Methyl Ethers; Oxprenolol; Phenyl Ethers; Practolol; Propanolamines; Propranolol; Structure-Activity Relationship | 1973 |
Comparison of beta-adrenergic blocking activities of propranolol, isopropylmethoxamine, sotalol, practolol, alprenolol, pindolol, oxprenolol and D-32 in the atria and trachea of the guinea-pig.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Butylamines; Dose-Response Relationship, Drug; Electric Stimulation; Female; Guinea Pigs; Heart Atria; Heart Rate; In Vitro Techniques; Male; Methoxamine; Muscle Contraction; Muscle, Smooth; Oxprenolol; Phenyl Ethers; Pindolol; Practolol; Propanolamines; Propranolol; Receptors, Drug; Sotalol; Trachea | 1974 |
GLC determination of propranolol, other beta-blocking drugs, and metabolites in biological fluids and tissues.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Body Fluids; Chromatography, Gas; Ethanolamines; Fluoroacetates; Humans; Isoproterenol; Mass Spectrometry; Myocardium; Oxprenolol; Practolol; Propranolol; Rats; Sotalol | 1974 |
Beta-blockade for hypertension.
Topics: Adrenergic beta-Antagonists; Alprenolol; Antihypertensive Agents; Humans; Hypertension; Oxprenolol; Pindolol; Propranolol | 1974 |
[Comparative study of various beta-adrenergic blockers in clinical anesthesiology--alprenolol, oxprenolol, propranolol and LB-46].
Topics: Adjuvants, Anesthesia; Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Alprenolol; Amino Alcohols; Anti-Arrhythmia Agents; Child; Child, Preschool; Female; Humans; Indoles; Infant; Male; Middle Aged; Oxprenolol; Propranolol; Sympatholytics | 1972 |
Cardiac toxicity of -lytic drugs.
Topics: 1-Propanol; Acetanilides; Adrenergic beta-Antagonists; Alprenolol; Amino Alcohols; Animals; Cresols; Ethanolamines; Guinea Pigs; Heart Atria; Heart Rate; In Vitro Techniques; Indoles; Muscle Contraction; Nitrobenzenes; Oxprenolol; Papaverine; Phenethylamines; Prenylamine; Propranolol; Propylamines; Sotalol; Sympatholytics; Verapamil | 1972 |
Cardioselective beta-adrenergic blockade.
Topics: Adrenergic beta-Antagonists; Alprenolol; Amino Alcohols; Animals; Heart; Humans; Hydroquinones; Isoproterenol; Neural Conduction; Organ Specificity; Oxprenolol; Phenethylamines; Propranolol; Propylamines; Receptors, Adrenergic | 1972 |
Clinical pharmacological evaluation of beta-receptor antagonists. I. The effect of propranolol, oxprenolol, alprenolol on some central circulatory parameters in patients with essential circulatory hyperkinesis (ECH).
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Alprenolol; Blood Circulation; Female; Heart; Hemodynamics; Humans; Male; Oxprenolol; Propranolol; Structure-Activity Relationship; Tachycardia | 1972 |
Clinical pharmacological evaluation of beta-receptor antagonists. II. The influence on the effect of isuprel by propranolol, oxprenolol, alprenolol in patients with essential circulatory hyperkinesis (ECH).
Topics: Adrenergic beta-Antagonists; Alprenolol; Blood Pressure; Cardiovascular Diseases; Drug Antagonism; Heart; Heart Rate; Hemodynamics; Humans; Isoproterenol; Muscle Contraction; Oxprenolol; Propranolol | 1972 |
[What is assured in treatment with beta receptor blockaders?].
Topics: Acetanilides; Adrenergic beta-Antagonists; Alprenolol; Amino Alcohols; Cresols; Heart Diseases; Humans; Hypertension; Isoproterenol; Oxprenolol; Parkinson Disease; Pheochromocytoma; Pindolol; Propranolol; Propylamines; Structure-Activity Relationship | 1972 |
Penetration of five beta-adrenergic antagonists into the rabbit eye after ocular instillation.
Topics: Administration, Topical; Adrenergic beta-Agonists; Alprenolol; Animals; Aqueous Humor; Chromatography, Gas; Oxprenolol; Practolol; Propranolol; Rabbits; Timolol | 1981 |
Variability in the preventive action of the B-blockers on genetic hypertension in the rat.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Blood Pressure; Dose-Response Relationship, Drug; Hypertension; Male; Metoprolol; Oxprenolol; Pindolol; Practolol; Propranolol; Rats; Rats, Inbred Strains; Species Specificity; Time Factors | 1980 |
A comparative study of the effects of metipranolol, propranolol, alprenolol, oxprenolol, pindolol and practolol on the circulation in experimental animals.
Topics: Alprenolol; Animals; Blood Circulation; Cats; Dogs; Female; Guinea Pigs; Heart Rate; Male; Metipranolol; Oxprenolol; Pindolol; Practolol; Propanolamines; Propranolol | 1980 |
Some metabolic effects of metipranolol, propranolol, alprenolol, oxprenolol, and practolol in rats.
Topics: Alprenolol; Animals; Glycogen; Lactates; Lactic Acid; Male; Metipranolol; Oxprenolol; Practolol; Propanolamines; Propranolol; Rats; Rats, Inbred Strains | 1980 |
Neonatal rat pinealocytes: typical and atypical characteristics of [125I]iodohydroxybenzylpindolol binding and adenosine 3',5'-monophosphate accumulation.
Topics: Alprenolol; Animals; Animals, Newborn; Butoxamine; Cyclic AMP; Epinephrine; In Vitro Techniques; Isoproterenol; Kinetics; Norepinephrine; Oxprenolol; Phenylephrine; Pindolol; Pineal Gland; Propranolol; Rats; Receptors, Adrenergic; Receptors, Adrenergic, beta | 1981 |
Propranolol, alprenolol and oxprenolol metabolism in the dog. Identification of N-methylated metabolites.
Topics: Alprenolol; Animals; Dogs; Gas Chromatography-Mass Spectrometry; Humans; Oxprenolol; Propranolol; Rats | 1981 |
Beta-blockers inhibit the modification of low-density lipoproteins by sodium hypochlorite in vitro.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Anti-Inflammatory Agents, Non-Steroidal; Arteriosclerosis; Atenolol; Bepridil; Biphenyl Compounds; Chemical Phenomena; Chemistry; Cholesterol Esters; Diclofenac; Free Radicals; Humans; Lipoproteins, LDL; Macrophages; Molecular Structure; Oxprenolol; Particle Size; Picrates; Sodium Hypochlorite; Spectrum Analysis; Thiobarbituric Acid Reactive Substances | 1997 |
Relationship between amount of beta-blockers permeating through the stratum corneum and skin irritation after application of beta-blocker adhesive patches to guinea pig skin.
Topics: Acebutolol; Administration, Cutaneous; Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Dermatitis, Irritant; Guinea Pigs; Male; Oxprenolol; Skin; Skin Absorption; Timolol | 1997 |
Evaluation of the immobilized artificial membrane phosphatidylcholine. Drug discovery column for high-performance liquid chromatographic screening of drug-membrane interactions.
Topics: Acebutolol; Acetonitriles; Adrenergic beta-Antagonists; Alprenolol; Aniline Compounds; Atenolol; Chromatography, High Pressure Liquid; Hydrogen-Ion Concentration; Membranes, Artificial; Metoprolol; Models, Chemical; Osmolar Concentration; Oxprenolol; Phosphatidylcholines; Pindolol; Propranolol; Reproducibility of Results; Timolol | 1998 |
In vitro permeability of eight beta-blockers through Caco-2 monolayers utilizing liquid chromatography/electrospray ionization mass spectrometry.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Atenolol; Biological Availability; Caco-2 Cells; Cell Membrane Permeability; Chromatography, Liquid; Epithelial Cells; Humans; Intestinal Absorption; Intestinal Mucosa; Mass Spectrometry; Metoprolol; Molecular Structure; Oxprenolol; Pindolol; Propranolol; Research Design; Timolol | 1998 |
Separation of enantiomers on HPLC chiral stationary phases based on human plasma alpha1-acid glycoprotein: effect of sugar moiety on chiral recognition ability.
Topics: Alprenolol; Benzoin; Bupivacaine; Carbohydrates; Chromatography, Gel; Chromatography, High Pressure Liquid; Electrophoresis, Capillary; Glycoside Hydrolases; Glycosylation; Humans; Hydantoins; Hydrogen-Ion Concentration; Molecular Weight; Orosomucoid; Oxprenolol; Phenylbutyrates; Propionates; Propranolol; Protein Binding; Silicon Dioxide; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Stereoisomerism; Structure-Activity Relationship; Warfarin | 2000 |
[Bromometric assay of alprenolol and oxprenolol].
Topics: Acetates; Adrenergic beta-Antagonists; Alkylation; Alprenolol; Bromine; Indicators and Reagents; Mass Spectrometry; Oxprenolol; Perchlorates; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Infrared; Spectroscopy, Fourier Transform Infrared; Sulfuric Acids | 2004 |
[Medium sized rings from alprenolol and oxprenolol].
Topics: Acetylation; Adrenergic beta-Antagonists; Alprenolol; Hydrolysis; Indicators and Reagents; Magnetic Resonance Spectroscopy; Oxprenolol; Titanium | 2004 |
Multivariate optimization approach for chiral resolution of drugs using human serum albumin in affinity electrokinetic chromatography-partial filling technique.
Topics: Alprenolol; Amines; Chromatography, Affinity; Electrophoresis, Capillary; Humans; Hydrophobic and Hydrophilic Interactions; Multivariate Analysis; Oxprenolol; Pharmaceutical Preparations; Promethazine; Propranolol; Serum Albumin; Stereoisomerism | 2005 |
Enantiomeric separation by using nano-liquid chromatography with on-column focusing.
Topics: Adrenergic beta-Antagonists; Alprenolol; Calibration; Chromatography, Liquid; Metoprolol; Nanotechnology; Oxprenolol; Particle Size; Propranolol; Reproducibility of Results; Silicon Dioxide; Stereoisomerism; Time Factors; Vancomycin | 2008 |
Optimization of 12 chiral analytes with 8 polymeric surfactants.
Topics: Alprenolol; Amino Acids; Benzodiazepinones; Buffers; Diamines; Electrophoresis, Capillary; Hydrogen-Ion Concentration; Lorazepam; Naphthalenes; Naphthols; Organophosphates; Oxazepam; Oxprenolol; Propanolamines; Propranolol; Stereoisomerism; Surface-Active Agents; Temazepam | 2008 |
The interactivities with lipid membranes differentially characterize selective and nonselective beta1-blockers.
Topics: Adrenergic beta-Antagonists; Alprenolol; Anesthesia; Anesthetics; Atenolol; Biomimetics; Lipid Bilayers; Lipids; Liposomes; Membranes, Artificial; Metoprolol; Oxprenolol; Propanolamines; Propranolol; Receptors, Adrenergic, beta | 2010 |
Identification of Alprenolol Hydrochloride as an Anti-prion Compound Using Surface Plasmon Resonance Imaging.
Topics: Alprenolol; Animals; Brain; Cell Line, Tumor; Imaging, Three-Dimensional; Magnetic Resonance Spectroscopy; Mice; Molecular Docking Simulation; Oxprenolol; Prions; Protein Binding; PrPSc Proteins; Recombinant Proteins; Surface Plasmon Resonance; Survival Analysis | 2019 |